The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
The FDA approved the combination of nivolumab plus ipilimumab and 2 cycles of platinum-doublet chemotherapy as first-line treatment for metastatic or ...
read more
I-Mab announced interim results from a study of TJM2 in patients with cytokine release syndrome associated with severe COVID-19.
read more
Moleculin Biotech announced the FDA has granted the Company's request for a Pre-IND Meeting to provide guidance regarding the Company's plan to study ...
read more
Aerpio and Quantum Leap announced an agreement has been reached to evaluate razuprotafib in a new randomized, investigational treatment arm in the ...
read more
The FDA approved brigatinib for ALK-positive metastatic non-small cell lung cancer.
read more
Novartis announced a new exploratory subgroup analysis of the Phase III MONALEESA-3 and MONALEESA-7 trials, to be presented during the ASCO20 Virtual ...
read more
Relmada announced the completion of its End-of-Phase 2 meeting with the FDA on its development program of REL-1017 for the adjunctive treatment of ...
read more
The FDA approved Kynmobi from Sunovion Pharmaceuticals.
read more
NeuroBo announced it received written communication from the FDA that the clinical development program for Gemcabene.
read more
AstraZeneca Pharmaceuticals
AstraZeneca and Daiichi Sankyo’s Enhertu has been granted Orphan Drug Designation in the US for gastric cancer.
read more
Anivive Lifesciences has filed a pIND request with the FDA for GC376 for COVID-19 in humans.
read more
Review the latest news and information on the Coronavirus Pandemic.
read more
Montefiore Health System and Albert Einstein College of Medicine are the evaluating an investigational drug in two separate, FDA-approved trials: one ...
read more
Review the latest news and information on the Coronavirus Pandemic.
read more
Apellis announced plans to submit a NDA for pegcetacoplan for the treatment of paroxysmal nocturnal hemoglobinuria in the second half of 2020.
read more